
TRICAPITAL
Description
TRICAPITAL is a well-established business angel syndicate based in Melrose, Scotland, specializing in early-stage investments. The syndicate comprises a network of private investors who pool their capital and expertise to support innovative companies demonstrating high growth potential. Their primary objective is to identify and nurture promising startups, providing crucial seed and early-stage funding to help them scale. This collaborative approach allows them to leverage diverse professional backgrounds and insights from their members.
While TRICAPITAL maintains a sector-agnostic investment approach, they have developed a notable track record in specific high-growth industries. These include life sciences, technology, and advanced manufacturing, where they have successfully backed numerous ventures. Geographically, their primary focus remains within Scotland, reflecting their commitment to fostering the local entrepreneurial ecosystem. However, they remain open to compelling investment opportunities across the broader United Kingdom, demonstrating a flexible yet regionally anchored strategy.
TRICAPITAL typically provides initial investments ranging from £100,000 to £500,000. Translating these figures, this means first checks are generally between approximately $125,000 and $625,000, based on recent exchange rates. These investments are often part of larger syndicated rounds, which can collectively reach up to £2 million, or approximately $2.5 million. This co-investment strategy sees TRICAPITAL frequently partnering with other angel groups, venture capital funds, and public sector funding bodies, enabling them to participate in more substantial funding rounds and provide greater capital support to their portfolio companies. Their ability to syndicate effectively underscores their strong network within the UK investment landscape.
Investor Profile
TRICAPITAL has backed more than 61 startups, with 5 new investments in the last 12 months alone. The firm has led 18 rounds, about 30% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series Unknown, Series B rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States, France.
- Strong thematic focus on Biotechnology, Software, Health Care.
- Led 4 rounds in the past year.
- Typical check size: $125K – $625K.
Stage Focus
- Seed (38%)
- Series Unknown (34%)
- Series B (8%)
- Series A (7%)
- Angel (5%)
- Undisclosed (5%)
- Convertible Note (2%)
- Series C (2%)
Country Focus
- United Kingdom (97%)
- United States (2%)
- France (2%)
Industry Focus
- Biotechnology
- Software
- Health Care
- Pharmaceutical
- Medical
- Medical Device
- Information Technology
- Security
- Manufacturing
- Cyber Security
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.